Prevalence and Factors Associated With Using Complementary Medicine Among Adults With Type 2 Diabetes in Primary Healthcare Centers of Al-Ahsa, Eastern Saudi Arabia

被引:0
作者
Al-Luwaym, Ali H. [1 ]
Al-Quwaidhi, Abdulkareem J. [1 ]
Al-Ghadeeb, Rahma B. [1 ]
机构
[1] Minist Hlth, Prevent Med Dept, Al Ahsa Health Cluster, Al Hasa, Saudi Arabia
关键词
primary healthcare center; saudi arabia; prevalence; type 2 diabetes mellitus; alternative medicine; complementary medicine; ALTERNATIVE MEDICINE;
D O I
10.7759/cureus.67953
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aim Type 2 diabetes mellitus (T2DM) is a major health problem in Saudi Arabia. The use of complementary and alternative medicine (CAM) for the management of T2DM is increasing, but there is limited research on its safety and efficacy. This study aimed to investigate the prevalence and factors associated with CAM use among patients with T2DM attending primary healthcare centers in Al-Ahsa, Saudi Arabia. Methods A cross-sectional study was conducted between January and March 2024 to assess CAM use among T2DM patients in Al-Ahsa. Data were collected through telephone interviews using a validated questionnaire covering demographics, diabetes information, and CAM use. A total of 499 participants completed the questionnaire. Results CAM use was reported by 106 (21.2%) participants, with fenugreek (51, 48.1%), cinnamon (48, 45.3%), and blackseed (29, 27.4%) being the most common. Key factors associated with CAM use included residence in the Eastern or Northern Region, older age, having diabetic complications, and lower frequency of doctor visits. Only 24 (22.6%) participants consulted their doctor about CAM, and 83 (78.3%) believed that CAM could prevent diabetes progression. Conclusion This study provides insights into the use of CAM among T2DM patients in Al-Ahsa, Saudi Arabia. The findings highlight the need for larger-scale longitudinal research to better understand the patterns and potential benefits and/or harms of CAM use. Developing targeted interventions and promoting evidence- based integration of CAM into the healthcare system could optimize patient care and encourage patient- provider communication regarding these therapies.
引用
收藏
页数:12
相关论文
共 20 条
  • [1] Prevalence and predictors of using complementary and alternative medicine among diabetic patients in Taif city, Saudi Arabia
    Abdullah, Rehab I.
    Allah, Ahmad Aman
    Mubarak, Ali S.
    Abdullah, Rayan I.
    Alzhrani, Sarah H.
    Alsufyani, Maram H.
    Alharthi, Salman J. A.
    Althomali, Reham O. H.
    [J]. JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2020, 9 (04) : 2092 - 2098
  • [2] Al-Kindi Rahma M, 2011, Sultan Qaboos Univ Med J, V11, P62
  • [3] A cross-sectional survey of herbal remedy taking by United Arab Emirate (UAE) citizens in Abu Dhabi
    AlBraik, Fatima Ali
    Rutter, Paul M.
    Brown, David
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 (07) : 725 - 732
  • [4] The Prevalence and Pattern of Using Complementary and Alternative Medicine in Saudi Patients With Diabetes: A Cross-Sectional Study
    Aljulifi, Mohammed Z.
    Alfhaid, Fahad
    Alshahrani, Awad
    Albatil, Khawlah A.
    Aljthalin, Raseel A.
    Alloboon, Farah
    Aljthalin, Raneem Abdulaziz
    Aljagwani, Arwa S.
    Alenzi, Dareen A.
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (10)
  • [5] Habits, Traditions, and Beliefs Associated With the Use of Complementary and Alternative Medicine Among Diabetic Patients in Al-Qassim Region, Saudi Arabia
    Almogbel, Ebtehal S.
    AlHotan, Fai M.
    AlMohaimeed, Yazeed A.
    Aldhuwayhi, Majd I.
    AlQahtani, Saud W.
    Alghofaili, Sultanah M.
    Bedaiwi, Barah F.
    AlHajjaj, Aswar H.
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (12)
  • [6] [Anonymous], 2004, WHO Guidelines on safety monitoring of herbal medicines in pharmacovigilance systems
  • [7] [Anonymous], 2022, IDF Diabetes Atlas
  • [8] Birdee G.S., 2010, Clinical Diabetes, V28, P147, DOI DOI 10.2337/DIACLIN.28.4.147
  • [9] International Diabetes Federation, 2021, About Us
  • [10] International Diabetes Federation, 2021, Saudi Arabia